Variant report
Variant | esv3344263 |
---|---|
Chromosome Location | chr8:66811573-66813646 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:66813325..66814889-chr8:66819143..66821210,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560445992 | chr8:66811594-66811595 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527485191 | chr8:66811648-66811649 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34580043 | chr8:66811660-66811661 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549197116 | chr8:66811668-66811669 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs117135079 | chr8:66811684-66811685 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569450506 | chr8:66811688-66811689 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530283860 | chr8:66811805-66811806 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537530423 | chr8:66811834-66811835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535531343 | chr8:66811890-66811891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549777235 | chr8:66811941-66811942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548703068 | chr8:66812043-66812044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538214387 | chr8:66812061-66812062 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558042144 | chr8:66812087-66812088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147276971 | chr8:66812111-66812112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534241898 | chr8:66812122-66812123 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534161049 | chr8:66812212-66812213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140853415 | chr8:66812241-66812242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375436489 | chr8:66812253-66812254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577593473 | chr8:66812350-66812351 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574105461 | chr8:66812381-66812382 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187275424 | chr8:66812382-66812383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113372881 | chr8:66812426-66812427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192733783 | chr8:66812438-66812439 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs367575877 | chr8:66812470-66812471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143088013 | chr8:66812481-66812482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556785778 | chr8:66812485-66812486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144705249 | chr8:66812495-66812496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113057267 | chr8:66812506-66812507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115042448 | chr8:66812510-66812511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553325208 | chr8:66812518-66812519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs199753066 | chr8:66812519-66812520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7815078 | chr8:66812530-66812531 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs7833489 | chr8:66812534-66812535 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs541044320 | chr8:66812541-66812542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199616552 | chr8:66812542-66812543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564073815 | chr8:66812546-66812547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9801952 | chr8:66812558-66812559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139319482 | chr8:66812565-66812566 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs199884881 | chr8:66812578-66812579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144114417 | chr8:66812582-66812583 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200066669 | chr8:66812591-66812592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531506387 | chr8:66812594-66812595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184715549 | chr8:66812610-66812611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115494446 | chr8:66812615-66812616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116366060 | chr8:66812631-66812632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189563194 | chr8:66812632-66812633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546988671 | chr8:66812768-66812769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566856163 | chr8:66812801-66812802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534196922 | chr8:66812820-66812821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192798854 | chr8:66812885-66812886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:66810600-66813400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr8:66810800-66811600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr8:66810800-66811600 | Enhancers | Stomach Mucosa | stomach |
4 | chr8:66810800-66813200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr8:66810800-66813400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr8:66811000-66811600 | Enhancers | Duodenum Mucosa | Duodenum |
7 | chr8:66811000-66813200 | Enhancers | HMEC | breast |
8 | chr8:66811200-66811600 | Enhancers | Primary T cells fromperipheralblood | blood |
9 | chr8:66811200-66811600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr8:66811200-66811600 | Enhancers | Esophagus | oesophagus |
11 | chr8:66811200-66811600 | Enhancers | Fetal Intestine Small | intestine |
12 | chr8:66811200-66811800 | Enhancers | Small Intestine | intestine |
13 | chr8:66811400-66811800 | Flanking Active TSS | NHEK | skin |
14 | chr8:66811600-66813800 | Weak transcription | Fetal Intestine Small | intestine |
15 | chr8:66811800-66813600 | Enhancers | NHEK | skin |
16 | chr8:66812800-66813800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr8:66813600-66814000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |